What EU Pharmaceutical Regulation (2022/0134) - Article 5: Marketing Authorisation Requirements requires
EU Pharmaceutical Regulation (proposed, replacing Directive 2001/83/EC) Article 5 maintains the core requirement that no medicinal product may be placed on the EU market without a marketing authorisation (MA) granted by the European…
This is a preview. The full record adds the complete summary, 8 workflow steps, 19 schema fields and 8 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: European Medicines Agency (EMA) · Version: 2.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52022PC0134
SHA-256 integrity: 5c5a82a7f64cb67dfdbbc75eef5d1143553bf19e792393ea16b0df7272951f44
Primary Citations — 8 traced to source
- https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52022PC0134
- https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32001L0083
+ 6 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-pharma-regulation-2022-0134-article-5-marketing-authorisation.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-pharma-regulation-2022-0134-article-5-marketing-authorisation.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-pharma-regulation-2022-0134-article-5-marketing-authorisation
- Back to registry: Browse all 10,102 compliance nodes